Calculate the HAS-BLED score to assess the risk of major bleeding in patients taking anticoagulants. Get a quick risk assessment.
Loading...
Found this tool helpful? Share it with your friends!
The HAS-BLED Score for Bleeding Risk is a crucial clinical tool designed to quantify the one-year risk of major bleeding in patients, especially those with atrial fibrillation receiving antithrombotic therapy. This score assists healthcare professionals in making informed decisions about anticoagulant management, balancing the benefits of stroke prevention against the potential for bleeding complications. It systematically evaluates key risk factors including Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile INR, Elderly (age >65), and Drugs (concomitant antiplatelet or NSAID use) or alcohol. By providing a clear, evidence-based risk stratification, the tool enhances patient safety, facilitates shared decision-making, and supports personalized treatment strategies.
Total HAS-BLED Score
0
Clinical Use: HAS-BLED is a scoring system developed to assess the 1-year risk of major bleeding in patients possessing atrial fibrillation who are currently on anticoagulants.